Valuation: Sight Sciences, Inc.

Market Cap 291M 255M 238M 219M 409M 27.83B 419M 2.83B 1.11B 13.77B 1.09B 1.07B 47.61B P/E 2026 *
-8.92x
P/E 2027 * -11.9x
Enterprise Value 253M 222M 207M 190M 356M 24.23B 365M 2.46B 962M 11.99B 950M 929M 41.45B EV / Sales 2026 *
2.94x
EV / Sales 2027 * 2.63x
Free-Float
80.02%
Yield 2026 *
-
Yield 2027 * -
1 day+0.75%
1 week+6.16%
Current month-1.48%
1 month-8.56%
3 months+34.51%
6 months-13.17%
Current year-32.66%
1 week 4.41
Extreme 4.41
5.58
1 month 4.41
Extreme 4.41
5.62
Current year 3.38
Extreme 3.378
8.19
1 year 3.11
Extreme 3.11
9.24
3 years 1.04
Extreme 1.04
9.31
5 years 1.04
Extreme 1.04
42.57
10 years 1.04
Extreme 1.04
42.57
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 56 2009-12-31
Chief Executive Officer 51 2009-12-31
Director of Finance/CFO 43 2025-11-04
Director TitleAgeSince
Director/Board Member 51 2009-12-31
Director/Board Member 56 2009-12-31
Chairman 74 2016-12-31
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Sell

Founder

-7,418 0.0136%
7/6/26 Sell

General Counsel

-12,733 0.0234%
7/2/26 Sell

Chief Operating Officer

-24,184 0.0444%
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%+6.16%+54.34%-39.25% 291M
+0.68%+7.39%-15.63%-4.20% 187B
+0.76%+6.90%-5.30%-0.80% 112B
-0.30%+6.00%+9.95%+70.78% 61.99B
+0.32%-4.03%+25.94%+44.22% 48.52B
+1.24%+9.95%-7.67%-39.93% 46.4B
-1.06%+7.80% - - 33.89B
+0.39%+5.19%-15.90%-43.24% 28.99B
+0.14%-5.85%+33.42%-7.66% 23.75B
+1.95%+11.52%+2.83%+2.08% 22.89B
Average +0.49%+4.54%+9.11%-2.00% 56.57B
Weighted average by Cap. +0.51%+5.54%-2.98%+4.53%

Financials

2026 *2027 *
Net sales 86.08M 75.64M 70.61M 64.8M 121M 8.25B 124M 837M 327M 4.08B 323M 316M 14.11B 95.76M 84.14M 78.54M 72.08M 135M 9.17B 138M 931M 364M 4.54B 360M 352M 15.69B
Net income -34.77M -30.56M -28.52M -26.17M -49M -3.33B -50.21M -338M -132M -1.65B -131M -128M -5.7B -28.69M -25.21M -23.53M -21.6M -40.43M -2.75B -41.43M -279M -109M -1.36B -108M -105M -4.7B
Net Debt -37.61M -33.05M -30.85M -28.31M -52.99M -3.6B -54.3M -366M -143M -1.78B -141M -138M -6.16B -38.44M -33.78M -31.53M -28.93M -54.16M -3.68B -55.5M -374M -146M -1.82B -144M -141M -6.3B
Logo Sight Sciences, Inc.
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Employees
186
Date Price Change Volume
26-07-29 US$5.340 +0.75% 136,275
26-07-28 US$5.300 +3.52% 132,437
26-07-27 US$5.120 +4.28% 72,723
26-07-24 US$4.910 +4.47% 145,495
26-07-23 US$4.700 -6.56% 237,337
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.340USD
Average target price
8.400USD
Spread / Average Target
+57.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SGHT Stock